483 Response Eli Lilly & Company Nov 2001

Patricia Dlugosz FDA, Robert Tollefsen FDA$119.00 - Available Now

FDA investigators audited the Eli Lilly & Company - Indianapolis, IN, United States facility and issued inspectional observation (via FDA 483) on 14 Nov 2001.

Product details

  • Category:
  • Inspection end: 14 Nov 2001
  • Location: Indianapolis, United States
  • FEI: 1819470
Add To Cart